Skip to content

Author

C. Ranjan

We have 3 of 12 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Phytochemical Horizons in Anticancer Drug Discovery: From Lead Molecules to Clinical Prospects

In the present day, there is a great concern about the second deadliest disease, cancer. An enormous number of mortalities rate is increasing every year because of cancer despite a few inter-cessions accessible. Advancements in potency with fewer side effects make anticancer treatment a promising area of drug devel...

Mahesh Agasa Ramu, S. Gunturu, Somashekhar M. Metri et al. · 0 citations
Review Open access Aug 2026

From Resistance to Renewal: Design Strategies and Structure–Activity Relationships of Novel EGFR Inhibitors in Breast Cancer: Mini Review

New findings on the design of small molecules that inhibit EGFR including pyrimidine‐5‐carbonitrile, thiazolyl‐pyrazolines, quinoxaline, quinazoline–sulfonamide hybrids, xanthine–chalcone conjugates, aminoquinolines, and pyridazine analogues are summarized.

Neelima Shrivastava, C. Ranjan · 0 citations
Jul 2026

In Silico Evaluation of 3,4-Dihydropyrimidin-2(1H)-Ones as Potential Antioxidant Agents: Molecular Docking and ADME/T Studies

The present study demonstrates that DHPM derivatives, specifically DHPM 22, may represent a promising lead for the development of new antioxidant derivatives, and further experimental studies are recommended to confirm their biological activities and therapeutic potential.

Chanda Ranjan, A. Mahesh, B. C. et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.